The companies agreed to sell most of their drugs to Medicaid at the prices they charge in European countries and to sell drugs directly to consumers through a planned TrumpRx website.
The Trump administration plans to create TrumpRx.gov, which will direct patients to the manufacturers’ direct-buy websites. Officials said the site would be operational next month.